Stock listing

NASDAQ:ITCI Intra-Cellular Therapies Inc Stock

Follow Intra-Cellular Therapies Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ITCI

$131.87 USD

Close on Apr 1, 2025 · No longer trades

Dec 27, 2013 to last close +1,219% · monthly closes, Dec 27, 2013 – Apr 1, 2025
Lowest – highest close
$7.26 – $131.92 USDSince Dec 27, 2013 · lowest Oct 1, 2019 · highest Mar 31, 2025

Delisted NASDAQ:ITCI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ITCI
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Intra-Cellular Therapies Inc on 6ix

Calls
10 calls with a replay · 10 with a transcript · latest Oct 30, 2024
Decks
2 decks · latest Feb 25, 2025

Events

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (February 2025)Merger or acquisition12 slidesFeb 25, 2025
Investor Presentation (January 2018)Investor deck28 slidesJan 8, 2018

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christopher D Alafi
Other companies: Stereotaxis, Inc. (Director · Jan 3, 2012 – May 7, 2012 · Past)
Director · Aug 29, 2013 – May 27, 2021 · Past
Eduardo Rene Salas
Other companies: ADMA Biologics Inc (Director · Since at least Dec 30, 2024)
Director · Jun 14, 2024 – Apr 2, 2025 · Past
Mark Neumann
Other companies: Veradermics, Incorporated (Chief Commercial Officer · Since at least Feb 3, 2026)
EVP, Chief Commercial Officer · Oct 15, 2018 – Apr 2, 2025 · Past
Robert L. Van Nostrand
Other companies: SELLAS Life Sciences Group, Inc. (Director · Since at least Feb 2, 2023)
Director · Mar 31, 2022 – Apr 2, 2025 · Past
Allen A FienbergVP of Business Development · Aug 29, 2013 – Aug 19, 2015 · Past
Lawrence J HinelineSVP of Finance, CFO · Jan 3, 2018 – Mar 7, 2024 · Past
Michael HalsteadPresident · Nov 17, 2020 – Apr 2, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Intra-Cellular Therapies Inc.